Key statistics
As of last trade Omeros Corp (3O8:STU) traded at 9.34, -35.32% below its 52-week high of 14.44, set on Jan 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.25 |
|---|---|
| High | 9.60 |
| Low | 9.17 |
| Bid | 9.37 |
| Offer | 9.42 |
| Previous close | 9.47 |
| Average volume | 801.78 |
|---|---|
| Shares outstanding | 70.90m |
| Free float | 68.92m |
| P/E (TTM) | -- |
| Market cap | 791.96m USD |
| EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of Feb 10 2026.
More ▼
Press releases
- Omeros Announces First Commercial Sales of YARTEMLEA®
- Omeros Announces New Date for YARTEMLEA® Approval Conference Call
- FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
- Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
- Omeros Corporation Reports Third Quarter 2025 Financial Results
More ▼
